Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Phase of Trial: Phase III
Latest Information Update: 09 Oct 2019
Price : $35 *
At a glance
- Drugs Neridronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal
- 12 Aug 2019 Status changed from active, no longer recruiting to discontinued.
- 05 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Jun 2018 According to a Grunenthal media release, the first patient has been enrolled in this trial.